Rapport Therapeutics RAPP Income Statement (2023-2026)

NASDAQ RAPP
$26.00 -0.07 (-0.27%)
As of: Nov 10, 2026 · 1:19 PM EST
Reported Financials

Rapport Therapeutics Quarterly Income Statement

Periods 14 quarters
Latest Sep 2026

Rapport Therapeutics reported net income of -$40.23M for the quarter ended Sep 2026. This income statement covers 14 quarters of results from Jun 2023 through Sep 2026, standardized by Business Quant from the company’s SEC filings.

Income StatementIncome Statement Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026 Sep2026
Revenue & cost
Revenue 20.00M
Operating items
Research & DevelopmentR&D 4.72M7.58M11.80M12.50M15.69M15.54M17.20M19.57M22.68M22.28M30.26M32.72M51.41M34.32M
Selling, General & AdministrativeSG&A 1.91M1.98M3.00M4.59M5.11M6.10M6.32M7.54M6.82M7.71M8.25M11.50M9.39M9.77M
Operating ExpensesOpex 6.63M9.56M14.79M17.09M20.80M21.64M23.52M27.11M29.50M29.99M38.51M44.22M60.81M44.09M
Operating IncomeOp. Inc -6.63M-9.56M-14.79M-17.09M-20.80M-21.64M-23.52M-27.11M-29.50M-29.99M-38.51M-24.22M-60.81M-44.09M
Non-operating items
Interest & Investment IncomeInt & Inv Inc 0.22M0.86M1.38M1.82M2.68M4.10M3.54M3.05M2.76M3.06M4.75M4.36M4.19M3.85M
Non Operating IncomeNon Op. Inc. 0.22M0.86M1.28M-5.58M2.68M4.10M3.54M3.05M2.76M3.06M4.75M4.36M4.19M3.85M
Net income details
EBIT -6.63M-9.56M-14.79M-17.09M-20.80M-21.64M-23.52M-27.11M-29.50M-29.99M-38.51M-24.22M-60.81M-44.09M
EBT -6.41M-8.71M-13.51M-15.28M-18.12M-17.54M-19.98M-24.06M-26.73M-26.93M-33.76M-19.86M-56.62M-40.24M
Tax ProvisionsTaxes 0.00M0.00M0.01M
Income After Tax -6.41M-8.71M-13.52M-15.28M-18.12M-17.54M-19.98M-24.06M-26.73M-26.93M-33.76M-19.86M-56.62M-40.24M
Income from Continuing OperationsIncome (Continuing) -6.41M-8.71M-13.52M-15.28M-18.12M-17.54M-19.98M-24.06M-26.73M-26.93M-33.76M-19.86M-56.62M-40.24M
Consolidated Net IncomeConsol Net Inc. -6.41M-8.71M-13.52M-15.28M-18.12M-17.54M-19.98M-24.06M-26.73M-26.93M-33.76M-19.86M-56.62M-40.24M
Income towards Parent CompanyParent Net Inc -6.41M-8.71M-13.53M-22.67M-18.12M-17.54M-19.98M-24.06M-26.73M-26.93M-33.78M-19.86M-56.62M-40.24M
Net Income towards Common StockholdersNet Income -6.41M-8.71M-13.52M-22.67M-18.12M-17.54M-19.98M-24.06M-26.73M-26.93M-33.76M-19.86M-56.62M-40.24M
Additional items
EPS (Basic) -4.45-5.70-8.98-11.07-1.70-0.50-0.96-0.68-0.75-0.71-0.87-0.42-1.19-0.84
EPS (Diluted) -4.45-5.70-8.98-11.07-1.70-0.50-0.96-0.68-0.75-0.71-0.87-0.42-1.19-0.84
Shares Outstanding 1.44M1.53M1.51M2.05M10.67M34.86M20.74M35.27M35.44M37.93M38.93M47.24M47.47M47.77M
Shares Outstanding (Diluted)Shares Outstanding (Dil.) 1.44M1.53M1.51M2.05M10.67M34.86M20.74M35.27M35.44M37.93M38.93M47.24M47.47M47.77M
Shares Outstanding (Entity)Shares Outstanding (Entity.) 1.44M1.53M1.51M2.05M10.67M36.58M20.74M36.50M36.50M37.93M38.93M47.81M47.96M47.77M
EBITDA -6.53M-9.54M-14.74M-16.94M-20.59M-21.42M-23.26M-26.86M-29.24M-29.73M-38.24M-23.99M-60.59M-43.89M

Rapport Therapeutics Income Statement API

Pull Rapport Therapeutics's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=RAPP&statement=IS&frequency=Quarter&period=all&api_key=YOUR_API_KEY